Tobias Sydendal Grand (Tobias S Grand)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

PharmacoEconomics

ClinicoEconomics and outcomes research : CEOR

PloS one

Journal of medical economics

Alk-Abelló A/S

University of Birmingham (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Alk-Abelló A/S Jan 01 2017 - Oct 31 2019

Denmark

Global Market Access Manager :: Global Market Access & Public Affairs

Education History

University of Birmingham Sep 01 2015 - Sep 01 2016

United Kingdom

MSC

University of Copenhagen Sep 01 2012 - Jun 01 2014

Denmark

MSC

University of Copenhagen Sep 01 2008 - Jun 01 2012

Denmark

BSC

Publications

Tobias Sydendal Grand, Shijie Ren, James A Hall, Daniel Oudin Åstrøm, Stephane Alexandre Regnier, Praveen Thokala
Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review. PharmacoEconomics 42 (6) (2024)
Tobias Sydendal Grand, Shijie Ren, James A Hall, Daniel Oudin Åstrøm, Stephane Alexandre Regnier, Praveen Thokala
Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review. PharmacoEconomics 42 (6) (2024)
Tobias Sydendal Grand, Shijie Ren, James A Hall, Daniel Oudin Åstrøm, Stephane Alexandre Regnier, Praveen Thokala
Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review. PharmacoEconomics (2024)
Tobias Sydendal Grand, Shijie Ren, James A Hall, Daniel Oudin Åstrøm, Stephane Alexandre Regnier, Praveen Thokala
Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review. PharmacoEconomics 42 (6) (2024)
Tobias Sydendal Grand, Shijie Ren, James A Hall, Daniel Oudin Åstrøm, Stephane Alexandre Regnier, Praveen Thokala
Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review. PharmacoEconomics 42 (6) (2024)
Richard F Pollock, Andreas K Slættanes, Henrik Brandi, Tobias Sydendal Grand
A Cost-Utility Analysis of SQ ® Tree SLIT-Tablet versus Placebo in the Treatment of Birch Pollen Allergic Rhinitis from a Swedish Societal Perspective. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Richard F Pollock, Andreas K Slættanes, Henrik Brandi, Tobias Sydendal Grand
A Cost-Utility Analysis of SQ ® Tree SLIT-Tablet versus Placebo in the Treatment of Birch Pollen Allergic Rhinitis from a Swedish Societal Perspective. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Christian Vogelberg, Eckard Hamelmann, Ulrich Wahn, Anne Domdey, Richard F Pollock, Tobias Sydendal Grand
Cost-Effectiveness Of The SQ® Grass SLIT-Tablet In Children With Allergic Rhinitis: A German Payer Perspective. ClinicoEconomics and outcomes research : CEOR 11 (2019)
Katherine Dick, Andrew Briggs, Robert Ohsfeldt, Tobias Sydendal Grand, Sarah Buchs
A quality-of-life mapping function developed from a grass pollen sublingual immunotherapy trial to a tree pollen sublingual immunotherapy trial. Journal of medical economics 23 (1) (2019)
Tobias Sydendal Grand, Hasan Basarir, Louise J Jackson
The cost-effectiveness of oral contraceptives compared to 'no hormonal treatment' for endometriosis-related pain: An economic evaluation. PloS one 14 (1) (2019)

Tobias Sydendal Grand.css-eqlu8i{font-size:small;padding-left:4px;} (Tobias S Grand)

Publication Activity (10 Years)

Top Topics

Top Venues

Tobias Sydendal Grand (Tobias S Grand)